Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d’intérêt en hémostase périopératoire (GIHP) – septembre 2015

ANESTHESIE & REANIMATION - Tập 2 - Trang 414-420 - 2016
Pierre Albaladejo1, Fanny Bonhomme2, Normand Blais3, Jean Philippe Collet4, David Faraoni5, Pierre Fontana6, Anne Godier7, Juan V. Llau8, Dan Longrois9, Emmanuel Marret10, Patrick Mismetti11, Nadia Rosencher12, Stéphanie Roullet13, Charles Marc Samama12, Jean-François Schved14, Pierre Sie15, Annick Steib16, Sophie Susen17
1Pôle d’anesthésie-réanimation, CS10217, CHU de Grenoble, 38043 Grenoble cedex 9, France
2Service d’anesthésiologie, hôpital universitaire de Genève, Genève, Suisse
3Hématologie et oncologie médicale, CHUM, hôpital Notre-Dame, Montréal, Canada
4Service de cardiologie, Assistance publique–Hôpitaux de Paris, CHU La Pitié Salpêtrière, 75013 Paris, France
5Département d’anesthésie pédiatrique, hôpital universitaire Reine Fabiola, avenue Jean Joseph Crocq 15, 1020 Bruxelles, Belgique
6Service d’angiologie et d’hémostase, hôpital universitaire de Genève, Genève, Suisse
7Service d’anesthésie-réanimation, Fondation Rothschild, 27, rue Manin, 75019 Paris, France
8Hospital clínic universitari, universidad Católica “San Vicente Mártir”, servicio de anestesiología-reanimación, Valencia, Espagne
9Département d’anesthésie-réanimation, Assistance publique–Hôpitaux de Paris, CHU Bichat–Claude-Bernard, 75018 Paris, France
10Institut hospitalier franco-britannique, 92300 Levallois Perret, France
11Service de pharmacologie, hôpital Bellevue, 25, boulevard Pasteur, 42100 Saint-Étienne, France
12Département d’anesthésie-réanimation, Assistance publique–Hôpitaux de Paris, CHU Cochin–Port-Royal, 75014 Paris, France
13Service d’anesthésie-réanimation, CHU Pellegrin, place Amélie Raba-Léon, 33076 Bordeaux, France
14Laboratoire central d’hématologieCHU de Montpellier, hôpital Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France
15Laboratoire d’hématologie, hôpital Purpan, place du Docteur Baylac, 31300 Toulouse, France
16Hôpitaux universitaires de Strasbourg, département d’anesthésiologie, hôpitaux universitaires de Strasbourg, 1, place Hôpital, 67000 Strasbourg, France
17Institut d’hématologie transfusion, CHRU de Lille, 2, avenue Oscar Lambret, 59000 Lille, France

Tài liệu tham khảo

Sié, 2011, Arch Cardiovasc Dis, 104, 669, 10.1016/j.acvd.2011.09.001 Sie, 2011, Chirurgies et actes invasifs chez les patients traités au long cours par un anticoagulant oral anti-IIa ou anti-Xa direct propositions du Groupe d’intérët en hémostase périopératoire (GIHP) et du groupe d’études sur l’hémostase et la thrombose (GEHT), Ann Fr Anesth Reanim, 30, 645, 10.1016/j.annfar.2011.06.018 Agence nationale de sécurité du médicament, 2014 Garcia, 2014, Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures, Blood, 124, 3692, 10.1182/blood-2014-08-595496 Healey, 2012, Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (re-ly) randomized trial, Circulation, 126, 343, 10.1161/CIRCULATIONAHA.111.090464 Sherwood, 2014, Circulation, 129, 1850, 10.1161/CIRCULATIONAHA.113.005754 Douketis, 2015, Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the re-ly trial, Thromb Haemost, 113, 625, 10.1160/TH14-04-0305 Beyer-Westendorf, 2014, Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective dresden noac registry, Eur Heart J, 35, 1888, 10.1093/eurheartj/eht557 Schulman, 2015, Perioperative management of dabigatran: a prospective cohort study, Circulation, 132, 167, 10.1161/CIRCULATIONAHA.115.015688 Winkle, 2014, Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban, Europace, 16, 1443, 10.1093/europace/euu196 Godier, 2015, Peri-procedural management of dabigatran and rivaroxaban: duration of anticoagulant discontinuation and drug concentrations, Thromb Res, 136, 763, 10.1016/j.thromres.2015.08.006 Douketis, 2015, Perioperative bridging anticoagulation in patients with atrial fibrillation, N Engl J Med, 373, 823, 10.1056/NEJMoa1501035 Siegal, 2012, Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates, Circulation, 126, 1630, 10.1161/CIRCULATIONAHA.112.105221 Haute Autorité de santé, 2008 Douketis, 2012, Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines, Chest, 141, e326S, 10.1378/chest.11-2298 Heidbuchel, 2015, Updated european heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation, Europace, 17, 1467, 10.1093/europace/euv309 Heidbuchel, 2013, Ehra practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary, Eur Heart J, 34, 2094, 10.1093/eurheartj/eht134 Rosencher, 2007, Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies, Anaesthesia, 62, 1154, 10.1111/j.1365-2044.2007.05195.x
Thông tin
Thông tin xuất bản

ANESTHESIE & REANIMATION

Tập 2

414-420

Thông tin tác giả